DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3q7vxb/bladder_cancer) has announced the addition of the "Bladder Cancer Treatment Drugs Markets in China" report to their offering.
China's demand for bladder cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.
Key Topics Covered:
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY
Companies Featured
- Shandong Qilu Pharmaceutical Co.,Ltd
- Hansen Pharmaceutical Co.,Ltd
For more information visit http://www.researchandmarkets.com/research/3q7vxb/bladder_cancer
